A detailed history of Systematic Alpha Investments, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Systematic Alpha Investments, LLC holds 279,303 shares of LLY stock, worth $222 Million. This represents 9.1% of its overall portfolio holdings.

Number of Shares
279,303
Previous 279,303 -0.0%
Holding current value
$222 Million
Previous $253 Million 2.15%
% of portfolio
9.1%
Previous 9.27%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $7.71 Million - $9.97 Million
42,703 Added 18.05%
279,303 $75.3 Million
Q1 2021

Apr 16, 2021

BUY
$164.32 - $212.72 $6.65 Million - $8.62 Million
40,500 Added 20.65%
236,600 $44.2 Million
Q4 2020

Apr 16, 2021

BUY
$130.46 - $172.63 $25.6 Million - $33.9 Million
196,100 New
196,100 $33.1 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Systematic Alpha Investments, LLC Portfolio

Follow Systematic Alpha Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Systematic Alpha Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Systematic Alpha Investments, LLC with notifications on news.